Outcome data for all AML patients independently of karyotype (total AML) and of cytogenetically normal AML (NK-AML) patients in the discovery cohort according to 46/1 haplotype. Comparisons are presented between 46/1 carriers (CT and CC genotypes of the single nucleotide polymorphism rs12343867) and 46/1 non-carriers (TT genotype of the single nucleotide polymorphism rs12343867).